Bioavailability

Bovine Serum Albumin in Caco-2 Permeability Testing and Effect on Papp Values Determined with Highly Protein Bound Compounds
Elke S. Perloff, BD GentestSM Contract Research Services; Sudarshan Kapadnis, BD GentestSM Contract Research Services; Andrew K Mason, BD GentestSM Contract Research Services; David M. Stresser, BD GentestSM Contract Research Services
Effect of compatibility on Isofraxidin pharmacokinetic after oral administrated with Yinxieling or Sarcandra Glabra (Thumb.) Nakai
Chuanjian Lu, Guangdong provincial academy of Chinese Medicine; Jinghong Yu, guangzhou university of Chinese medicine; Buqing Lu, guangzhou university of Chinese medicine; Rui Zhi Zhao, guangzhou university of Chinese Medicine
Evaluation of Oral Bioavailability and Intestinal Availability from Pharmacokinetic Changes Associated with Drug-Drug Interaction
Akihiro Hisaka, The University of Tokyo Hospital; Akiko Mori, The University of Tokyo Hospital; Saori Koh, Pharmaceuticals Research Center, Asahi Kasei Pharma Corporation; Ayako Tsukihashi, The University of Tokyo Hospital; Hirotaka Ando, The University of Tokyo Hospital; Hiroshi Suzuki, The University of Tokyo Hospital
Methodology Optimisation in Intestinal Microsome Preparation: Implications for Scaling Approaches?
Oliver Hatley, University of Manchester; Christopher Jones, AstraZeneca; Aleksandra Galetin, University of Manchester; Amin Rostami-Hodjegan, University of Manchester
Pharmacokenetics comparison of astilbin after orally administered with Yin Xie Ling or Smilacis glabrae in rats
Yin Jie Wang, Guangzhou university of Chinese medicine; Rui Zhi Zhao, guangzhou university of Chinese Medicine; Chuan jian Lu, Guangzhou university of Chinese medicine
Pharmacokinetics and Oral Bioavailability of a Novel PPAR-Sparing Insulin Sensitizer and Its Pharmacologically Active Hydroxy Metabolite in Monkeys and Humans
Wade J. Adams, Metabolic Solutions Development Company; Jonathan G. Bissland, MPI Research, Inc.; Carter D. Brooks, Jasper Clinic, Inc.; Lori L. Cochrane, MPI Research, Inc.; Jerry R. Colca, Metabolic Solutions Development Company; M. Melissa Peet, MPI Research, Inc.; Natalie D. Schmock, MPI Research, Inc.; James T. VanderLugt, Metabolic Solutions Development Company
Prediction of Time-Course of Drug Concentrations in Enterocytes and Blood during Oral Absorption by Translocation Model, a New Physiological Pharmacokinetic Model for Gastrointestinal Tracts
Hirotaka Ando, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo; Akihiro Hisaka, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo; Hiroshi Suzuki, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo
Preparation of controlled release tablets of Rheum palmatum and evaluation in vivo
Ruizhi Zhao, Guangzhou university of triditional Chinese medicine
Substantial Impact of P-glycoprotein on Bioavailability in Rats (1)
Megumi Irie, Astellas Pharma Inc.; Fumihiro Nakamori, Astellas Pharma Inc.; Ai Tamura, Astellas Pharma Inc.; Katsuhiro Yamano, Astellas Pharma Inc.; Shigeyuki Terashita, Astellas Pharma Inc.; Toshio Teramura, Astellas Pharma Inc.
Substantial Impact of P-glycoprotein on Bioavailability in Rats (2)
Fumihiro Nakamori, Astellas Pharma Inc.; Megumi Irie, Astellas Pharma Inc.; Ai Tamura, Astellas Pharma Inc.; Katsuhiro Yamano, Astellas Pharma Inc.; Shigeyuki Terashita, Astellas Pharma Inc.; Toshio Teramura, Astellas Pharma Inc.